Pathophysiology of Osteoporosis. New Mechanistic Insights.

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 3, 2012, Pages 475-486

  Armas, Laura A G ^a   Recker, Robert R ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone quality; Mechanical loading; Microdamage; Osteoporosis; Remodeling

Indexed keywords

CATHEPSIN K; COLLAGEN TYPE 1; ESTROGEN;

AGING; BONE DENSITY; BONE DEVELOPMENT; BONE INJURY; BONE REMODELING; BONE STRESS; BONE STRUCTURE; CORTICAL BONE; DRUG EFFECT; ESTROGEN DEFICIENCY; FRACTURE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INTRACELLULAR SIGNALING; MECHANICAL STRESS; MENOPAUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ANIMALS; BONE AND BONES; BONE REMODELING; FEMALE; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES;

EID: 84864819754     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.04.006     Document Type: Review

References (68)

1. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993, 341(8837):72-75.
2. Carmona R. Bone health and osteoporosis. A report of the Surgeon General 2004, US Department of Health and Human Services, Rockville, MD.
3. Bilezikian J.P. Osteoporosis in men. J Clin Endocrinol Metab 1999, 84(10):3431-3434.
4. Osteoporosis. JAMA 1984, 252(6):799-802.
5. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285(6):785-795.
6. Muschitz C., Patsch J., Buchinger E., et al. Prevalence of vertebral fracture in elderly men and women with osteopenia. Wien Klin Wochenschr 2009, 121(15-16):528-536.
7. Siris E.S., Brenneman S.K., Barrett-Connor E., et al. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 2006, 17(4):565-574.
8. Akhter M.P., Lappe J.M., Davies K.M., et al. Transmenopausal changes in the trabecular bone structure. Bone 2007, 41(1):111-116.
9. Stepan J.J., Burr D.B., Pavo I., et al. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone 2007, 41(3):378-385.
10. Bala Y., Bare S., Boivin G., et al. Secondary mineralization and the microhardness of bone measured across menopause in women. J Bone Miner Res 2009, 24(Suppl 1). Available at:, Accessed May 16, 2012. http://www.asbmr.org/Meetings/AnnualMeeting/Abstracts09.aspx.
11. McKinlay S.M., Bifano N.L., McKinlay J.B. Smoking and age at menopause in women. Ann Intern Med 1985, 103(3):350-356.
12. Heaney R.P., Recker R.R., Omaha P.D. Menopausal changes in calcium balance performance. Nutr Rev 1983, 41(3):86-89.
13. Recker R., Lappe J., Davies K., et al. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2000, 15(10):1965-1973.
14. Cooper D.M., Thomas C.D., Clement J.G., et al. Age-dependent change in the 3D structure of cortical porosity at the human femoral midshaft. Bone 2007, 40(4):957-965.
15. Yeh J.K., Liu C.C., Aloia J.F. Effects of exercise and immobilization on bone formation and resorption in young rats. Am J Physiol Endocrinol Metab 1993, 264(2):E182-E189.
16. Turner R.T., Bell N.H. The effects of immobilization on bone histomorphometry in rats. J Bone Miner Res 1986, 1(5):399-407.
17. Recker R., Lappe J., Davies K.M., et al. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res 2004, 19(10):1628-1633.
18. Jaworski Z., Liskova-Kiar M., Uhthoff H. Effect of long-term immobilisation on the pattern of bone loss in older dogs. J Bone Joint Surg Br 1980, 62(1):104-110.
19. Burr D.B., Turner C.H., Naick P., et al. Does microdamage accumulation affect the mechanical properties of bone?. J Biomech 1998, 31(4):337-345.
20. Cardoso L., Herman B.C., Verborgt O., et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res 2009, 24(4):597-605.
21. Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 2008, 42(4):606-615.
22. LeBlanc A.D., Spector E.R., Evans H.J., et al. Skeletal responses to space flight and the bed rest analog: a review. J Musculoskelet Neuronal Interact 2007, 7(1):33-47.
23. Parfitt A.M., Mathews C.H., Villanueva A.R., et al. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 1983, 72(4):1396-1409.
24. Garnero P., Sornay-Rendu E., Chapuy M., et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996, 11(3):337-349.
25. Riggs B.L., Melton L.J., O'Fallon W.M. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 1996, 18(Suppl 3):197S-201S.
26. Cummings S.R., Karpf D.B., Harris F., et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002, 112(4):281-289.
27. Sarkar S., Mitlak B.H., Wong M., et al. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 2002, 17(1):1-10.
28. Watts N.B., Geusens P., Barton I.P., et al. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res 2005, 20(12):2097-2104.
29. Watts N.B., Cooper C., Lindsay R., et al. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom 2004, 7(3):255-261.
30. Austin M., Yang Y., Vittinghoff E., et al. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res 2012, 27(3):687-693.
31. Boivin G., Bala Y., Doublier A., et al. The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone 2008, 43(3):532-538.
32. Boivin G., Meunier P.J. The mineralization of bone tissue: a forgotten dimension in osteoporosis research. Osteoporos Int 2003, 14(Suppl 3):S19-S24.
33. Heaney R.P. Is the paradigm shifting?. Bone 2003, 33(4):457-465.
34. Keshawarz N.M., Recker R.R. Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis. Metab Bone Dis Relat Res 1984, 5(5):223-228.
35. Heaney R.P., Barger-Lux M.J., Davies K.M., et al. Bone dimensional change with age: interactions of genetic, hormonal, and body size variables. Osteoporos Int 1997, 7(5):426-431.
36. Ahlborg H.G., Johnell O., Turner C.H., et al. Bone loss and bone size after menopause. N Engl J Med 2003, 349(4):327-334.
37. Leblanc A.D., Schneider V.S., Evans H.J., et al. Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 1990, 5(8):843-850.
38. Matheson G.O., Clement D.B., McKenzie D.C., et al. Stress fractures in athletes. A study of 320 cases. Am J Sports Med 1987, 15(1):46-58.
39. Khan K., Brown J., Way S., et al. Overuse injuries in classical ballet. Sports Med 1995, 19(5):341-357.
40. Milgrom C., Giladi M., Stein M., et al. Stress fractures in military recruits. A prospective study showing an unusually high incidence. J Bone Joint Surg Br 1985, 67(5):732-735.
41. Herman B.C., Cardoso L., Majeska R.J., et al. Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage. Bone 2010, 47(4):766-772.
42. Bonewald L.F. The amazing osteocyte. J Bone Miner Res 2011, 26(2):229-238.
43. Mulcahy L.E., Taylor D., Lee T.C., et al. RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone 2011, 48(2):182-188.
44. Carter D.R., Hayes W.C. Compact bone fatigue damage: a microscopic examination. Clin Orthop Relat Res 1977, 127(127):265-274.
45. Schaffler M.B., Choi K., Milgrom C. Aging and matrix microdamage accumulation in human compact bone. Bone 1995, 17(6):521-525.
46. Liu Y., Liu Y., Recker R., et al. Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol 2003, 177(2):147-196.
47. Pocock N.A., Eisman J.A., Hopper J.L., et al. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1987, 80(3):706-710.
48. Tylavsky F.A., Bortz A.D., Hancock R.L., et al. Familial resemblance of radial bone mass between premenopausal mothers and their college-age daughters. Calcif Tissue Int 1989, 45(5):265-272.
49. Clinical aspects of metabolic bone disease: Proceedings of the International Symposium on Clinical Aspects of Metabolic Bone Disease, Henry Ford Hospital. Detroit (MI), June 26-29, 1972. Henry Ford Hospital International Symposium. Excerpta Medica, 1973.
50. Efstathiadou Z., Tsatsoulis A., Ioannidis J.P.A. Association of collagen Iα 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 2001, 16(9):1586-1592.
51. Sobacchi C., Vezzoni P., Reid D.M., et al. Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif Tissue Int 2004, 74:35-41.
52. Uitterlinden A.G., Arp P.P., Paeper B.W., et al. Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 2004, 75(6):1032-1045.
53. Silverman S.L. Sclerostin. J Osteoporos 2010, 2010:941419.
54. Johnson M.L., Gong G., Kimberling W., et al. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13). Am J Hum Genet 1997, 60(6):1326-1332.
55. Akhter M.P., Wells D.J., Short S.J., et al. Bone biomechanical properties in LRP5 mutant mice. Bone 2004, 35(1):162-169.
56. Mao J., Wang J., Liu B., et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 2001, 7(4):801-809.
57. Johnson M.L. The high bone mass family-the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuronal Interact 2004, 4(2):135-138.
58. Akhter M.P., Alvarez G.K., Cullen D.M., et al. Disuse-related decline in trabecular bone structure. Biomech Model Mechanobiol 2011, 10(3):423-429.
59. Weitzmann M.N., Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 2005, 208:154-168.
60. Hughes D.E., Dai A., Tiffee J.C., et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996, 2(10):1132-1136.
61. Kousteni S., Bellido T., Plotkin L.I., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001, 104(5):719-730.
62. Uhthoff H.K., Jaworski Z.F. Bone loss in response to long-term immobilisation. J Bone Joint Surg Br 1978, 60(3):420-429.
63. Weitzmann M.N., Roggia C., Toraldo G., et al. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002, 110(11):1643-1650.
64. Gilbert L., He X., Farmer P., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000, 141(11):3956-3964.
65. Cenci S., Toraldo G., Weitzmann M.N., et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A 2003, 100(18):10405-10410.
66. Giorgio M., Trinei M., Migliaccio E., et al. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?. Nat Rev Mol Cell Biol 2007, 8(9):722-728.
67. Manolagas S.C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010, 31(3):266-300.
68. Russell S.J., Kahn C.R. Endocrine regulation of ageing. Nat Rev Mol Cell Biol 2007, 8(9):681-691.